45 results about "Behavior disorder" patented technology

A novel non-invasive magnetic stimulator is used to modulate electrical activity of a patient's vagus nerve. Parameters of the stimulation are selected in such a way as to induce a state of euphoria in the patient. The methods and devices may be used for anesthesia, or to treat insomnia, depression, or premenstrual syndromes. They may be used as substitution withdrawal tools for individuals who otherwise would depend on substances and behaviors to achieve a euphoric state of mind, particularly individuals who abusively consume drugs, alcohol or food, or who exhibit behavioral disorders such as compulsive gambling. The devices and methods may also be used to prevent, manage, or relieve stress.

The invention discloses an attention training system based on brain electricity and movement state feedback and a method thereof; the training system comprises a calculation analysis device and a signal collecting device; the signal collecting device comprises at least one sensor; the calculation analysis device is connected with at least one sensor to acquire the collecting signal of the sensor; at least one sensor comprises a brain electricity sensor for detecting the brain electricity signal and / or a movement sensor for collecting the movement state; the calculation analysis device comprises a signal receiving module, a processing analysis module, a feedback instruct module and an application program module. The attention training system based on brain electricity and movement state feedback and the method thereof can effectively solve the symptoms of inattention, hyperactivity and other various behavior disorders.

The invention belongs to the technical field of video monitoring and in particular relates to a video-based intelligent flight vehicle tracking system. The system comprises a surveillance camera, a tripod head, a converter, a video analytics module and a tripod head control and analysis module, which are arranged on an approach tower and a display screen arranged in an observation room. The invention utilizes the characteristic of computer vision to construct a real-time video monitoring and detecting module and the tripod head control algorithm to construct the tripod head control and analysis module. The flight vehicle tracking system can automatically track the trajectory of the flight vehicle, reduce the consumption of manpower resources of the airport for monitoring the flight vehicle and overcome the difficulties of extracting and tracking an object in a moving background video; the monitoring video can be used to realize automatic and intelligent tracking and video analysis so as to increase the monitoring quality; and the system can be used to monitor and record all the takeoff and landing process of flight vehicles at the airport and analyze the behavior disorder of the takeoff and landing process.

The invention features methods and systems for the diagnosis of ADHD and related disorders. The methods and systems of the invention can also be used to ascertain how much benefit an individual would derive from a particular therapy. One method of diagnosing ADHD or a related disorder in a subject comprising the steps of: (i) providing motor activity data having been collected by using a motion analysis device to record movements of said subject; (ii) analyzing said motor activity data to calculate a value for a measure of inhibitory control in said subject; and (iii) on the basis of said value, diagnosing said subject.

The invention discloses a ketogenic diet formula milk and a preparation method thereof and aims to solve the technical problem that convenience is provided for a patient to have food therapy through ketogenic diet. The ketogenic diet formula milk contains the following components per 100 g: 1.5-12.5 g of fat, 0-5 g of protein, 0-0.5 g of carbohydrate, 0-0.6 g of flavoring, 0-1.2 g of nourishing essence and the balance of liquid milk. The preparation method comprises the step of uniformly mixing fat, protein, carbohydrate, flavoring, nourishing essence and the liquid milk according to the prior art. Compared with the prior art, the ketogeic diet formula milk takes human milk and animal milk of which metabolizable sugar is removed as the main raw material, adopts a nutrient formula close to physiological needs, has a good mouthfeel, is easily accepted by the patient, is convenient to take, is suitable for treating epilepsy, diabetes, all kinds of tumors, behavior disorder, autism, brain and spinal cord injuries, and adiposity, and is also suitable for normal people to lose weight and change the structure of the main nutrients of the body, as well as for animal experiments.

The present invention relates to a method for treating a behavior disorder comprising the administration of a therapeutically effective amount of antihistamine, such as ceterizine, fexofenadine; loratadine, and desloratadine. The behavioral disorders may include ADHD, anxieity, depression, and autism. The method may include the administration of the antihistamine in combination with a stimulant medication, such as methylphenidate, thereby to achieve a synergistic effect. In any event, the amount of antihistamine and / or stimulant is effective to downregulate neurotrophic factors such as nerve growth factor or CD40. The invention is also directed to a method of preventing the onset of behavior disorders in patients presenting with symptoms of allergic rhinitis.

The present invention is medicine composition for treating cerebral ischemia and its medicinal application. The medicine composition has ginsenoside and salvianolic acid as main components. It can reduce the cerebral infarction area obviously, reduce behavior disorder caused by cerebral tissue necrosis obviously, and reach the aim of treating cerebral blood supply insufficiency, cerebral thrombosis, cerebral embolism, cerebral vascular spasm, senile dementia, etc.

The invention discloses an instrument system for digitalized intervention treatment of autistic children and relates to a digitalized intervention instrument system for treatment of child autism. The instrument system consists of a health cloud platform, a smart home device, a home nursing customer service system and a remote consultation system, wherein the smart home device comprises a home computer and a mobile terminal and is provided with a login module, a training module and a communication module, and the training module comprises a continuous attention training template, a visual perception training template, a logic and thought template and a numerical concept and memory skill template. The instrument system is an instrument system which is applied to integral visual and hearing sense training for treatment of child autism and can provide a more professional and effective treatment and rehabilitation means for people who suffer from development behavior disorder.

The invention discloses a method and system for monitoring a terminal behavior disorder. The method includes the steps that a mobile management unit conducts monitoring on behaviors of a terminal, and when the condition that a monitoring event occurs is detected, an event report is sent to a machine type communication interoperating function entity (MTC IWF); the MTC IWF sends an information inquiry requesting signal to a home subscriber server (HSS) and receives an information inquiry feedback signal which is returned by the HSS; the MTC IWF sends the monitoring event report to a MTC server according to information in the information inquiry feedback signal. According to the method and system for monitoring the behavior disorder, detecting and reporting on the terminal behavior disorder are achieved.

The present invention is one kind of red peony injection prepared with red peony root as material and through alcohol extraction, n-butanol extraction or macroporous resin purification, and adding proper amount of medicinal supplementary material and injection water. It is stable and may be used in intramuscular injection, intravenous injection and intravenous instillation. Pharmacodynamic experiment shows that the medicine of the present invention can improve the behavior disorder of rat with cerebral infarction obviously, reduce the area of cerebral infarction, decrease water content in infracted brain tissue, reduce the peroxidation damage of lipoid in brain tissue and raise the acute oxygen lack tolerance of mouse and thus has excellent treat effect on cerebral infarction.

The present invention provides a new use of saponins X of dipsacus asperoides, more conctretely relates to the application of the saponins X of dipsacus asperoides in preparing a medicine for treatingor preventing cardiovascular and cerebrovascular diseases. Compared with the nifedipine, the saponins X of dipsacus asperoides described by the present invention can obviously decrease the rising oflimb-lead electrocardiogram J point and reduce the ischemic areas in treating rat myocardial ischemia; and compared with nimodipine, the saponins X of dipsacus asperoides described by the present invention can obviously improve rat behavior disorder and reduce the ischemic areas in treating local cerebral ischemic injury.

The invention discloses a digital auditory integrated training system, which comprises a signal source, a power supply, a host and a signal receiving device, the host is electrically connected with the power supply, the signal source is connected with the host by a signal line, and the signal receiving device is communicated and connected with the host. The digital auditory integrated training system of the invention can correct the disorder phenomena of the auditory system on the voice treatment and stimulate the cerebral cortex by listening to a group of music after filtration and modulation, thus achieving the purpose of improving behavior disorders and emotional disorders. The digital auditory integrated training system is safe and reliable, the treatment has no side effects which are serious and existed for a long time, and the digital auditory integrated training system is applicable to: pervasive developmental disorder (PDD), including autism (Infantile Autism) and Asperger syndrome; attention deficit hyperactivity disorder (ADHD); special speech and language developmental disorder (SLD); emotion disorder (ED); learning disorder (LD) and so on.

The invention discloses a lipidosome modified gold nanoparticle compound and an application thereof in Parkinson's disease treatment. The gold nanoparticle compound is a gold nanoparticle which is wrapped with lipidosome and absorbs plasmids capable of interfering alpha-synuclein synthesis, and the surface of the gold nanoparticle compound is modified with nerve growth factors and ducosahexenoic acid. With the adoption of the prepared lipidosome modified gold nanoparticle composite material, on the premise that the problem of serious adverse effects of chemical medicines and traditional transfection reagents is solved, the plasmids capable of interfering alpha-synuclein synthesis are transfected into cells and interfere the alpha-synuclein synthesis so as to treat dyskinesia and exploration disability of a mouse with Parkinson's disease, and it is found that the lipidosome modified gold nanoparticle compound can improve athletic and exploring abilities of the mouse with Parkinson's disease by interfering expression of alpha-synuclein in the brain and has great significance and application value for treatment of the Parkinson's disease and improvement of behavior disorder.

The invention relates to an intelligent security and protection system which comprises wideband video security and protection equipment, a shell, a power interface, a duty management module, an important protection task module and a video behavior analysis module, wherein the duty management module is used for creating a duty task, executing the duty task and recording and inquiring the execution condition; the important protection task module is used for creating important protection tasks and performing route description and video grouping on the important protection task; the video behavior analysis module is used for analyzing abnormal behaviors in video images by virtue of an image analysis treatment technology, a computer vision technology, a computer network technology and an artificial intelligence technology and giving out an alarm after discovering the behavior disorder. The intelligent security and protection system can be used for presenting the current police strength state and operation locus in real time, presenting videos for automatic route description and grouping of important protection tasks; by virtue of intelligent analysis on the video images and alarming for the abnormal behaviors, beforehand and event real-time early warning service is provided for working personnel.

Use of Human Chorionic Gonadotropin (hCG) by oral-sublingual or injectable route for the treatment of several food disorders, as an appetite-suppressant agent, food compulsiveness as well as all of those pathologies related to hunger and / or appetite modifications, including overweight, obesity, anorexia, bulimia, emotional hyperphagia, without excluding other pathologies associated to overingestion or reduced ingestion. It also includes its use for the treatment of behavior disorders associated with an increased ingestion, either behavior disorders, neurosis, borderline personality disorders or psychosis, without excluding other psychosomatic disorders.

The invention discloses an application of aspirin in treatment of cognitive and behavioral disorders after epilepsy. The inventor creates a lithium chloride-pilocarpine induced rat model of chronic epilepsy, detects the spatial learning and memory of the rat through a Morris water maze, detects the behavior depression of the rat through a tail suspension test, and finds that the cognitive function and behavior disorder of the epileptic rat are obviously perfected when being dosed with the aspirin at the chronic epilepsy attack stage.

The invention relates to an eyeshade, in particular to an eyeshade for monitoring and estimating rapid eye movement sleep behavior disorder; the eyeshade comprises a hook-loop fastener, a processor, a distance sensor, an MEMS (micro-electrochemical systems) motion sensor, a wireless communication module, a rechargeable battery, a state indictor light, a storage card, a power switch key and a PCB (printed circuit board); the processor, the wireless communication module and the storage card are integrated to the PCB, the distance sensor arranged in the eyeshade is used for measuring sleep state of a user, the MEMS motion sensor disposed inside is capable of monitoring body movement amplitude and frequency of a human body, and data is stored in the storage card or transmitted to the background via the wireless communication module after being analyzed via the processor. The eyeshade has the advantages of availability for direct wearing, no installation is required, and the eyeshade is simple, convenient and comfortable to use.

The present invention provides a method of treatment of a neuropsychiatric disorder characterized by repetitive pheno-type, comprising administering to a human or non-human subject in need thereof a therapeutically effective dose of a pharmaceutical composition comprising at least one active agent selected from a group of active agents comprising CB2 receptor inverse agonists and mixed CB2 / SERM ligands. The present invention further provides pharmaceutical compositions comprising 4′-0-methylhonokiol, raloxifene, and their derivatives, HU-308 and / or BCP.

An oral function and dysfunction quantification device that automatically records the amount of time required for a laboratory animal to gnaw through multiple obstructions in a tube comprising a confinement tube and spring-loaded polymer dowels that actuate timers to precisely record the time required for a rodent to complete a discrete gnawing task. The investigation of human orofacial pain requires an animal test that objectively measures impairment secondary to pain during an oral function (gnawing) that is analogous to behavior that elicits pain in human patients (chewing). The device can also evaluate behavioral change secondary to complex disorders such as anxiety and depression and facilitate evaluation of molecular mechanisms and pharmacologic therapies relevant to chronic orofacial pain and behavioral disorders.

The invention relates to application of centella selected triterpenes (CST) to preparing medicines or health foods or foods for preventing or treating senile dementia. The centella selected triterpenes refers to a compound made of a mixture or a single ingredient which is extracted from Centella asiatic L.Urban., and the content of triterpenoid (asiaticoside, madecassoside, asiatic acid, madasiatic acid and the like) is higher than 20%. Animal experiment results indicate that the centella selected triterpenes can obviously improve hypomnesis, the cognitive function and the behavior disorder of injection beta-amyloid protein (Abata-amyloid protein) molding animals or ventricle injection streptozotocin molding animals, and it is indicated that the centella selected triterpenes have the important application value on preventing and treating the senile dementia in clinic.

An implanted flexible biological electrode comprises an electrode simulation contact blade, a metal ring and a metal micro guide wire. The electrode simulation contact blade is communicated with the metal ring through the metal micro guide wire. Insulation layers formed by insulation materials in an injection molding mode are arranged outside the electrode simulation contact blade, the metal ring and the metal micro guide wire, and the surface of the electrode simulation contact blade and the surface of the metal ring are exposed out of the insulation layers. According to a manufacturing method of the implanted flexible biological electrode, the two ends of the helical metal micro guide wire are connected with the electrode simulation contact blade and the metal ring of a connecting end in sequence in a welding mode, the packaging is carried out, finally, finishing is carried out, a packaging sprue gate is removed, and the metal of the electrode simulation contact blade and metal of the metal ring of the connecting end are exposed out. The implanted flexible biological electrode is simple in process and easy to manufacture, the implanted flexible biological electrode is implanted close to the Phil neurons of the human leg, the metal ring is connected with an external circuit, electric signals are provided for the electrode simulation contact blade, and pulse electrical signal simulation is provided for the nerve at the position of the target spot of the leg. The implanted flexible biological electrode is suitable for treating lower limb behavior disorder diseases caused by hemiplegia in clinical medicine.

The invention discloses an application of an amantadine-gardenia amide A heterozygote compound in a drug for treating Parkinson's disease, and a structure of the compound is as shown in formula I. Thecompound can increase a DA level in a Parkinson's cell model, can inhibit the synthesis of an NMDA receptor by inhibiting the protein expression of NR1, thereby inhibiting the internal flow of extracellular Ca<2+>, so that the activity and protein level of i-NOS can be decreased, the NO is significantly decreased, the necrocytosis is reduced, the nerve cell apoptosis can be resisted, and an effect for protecting the nerves can be realized. Being applied to a mice Parkinson's model, the compound can improve dyskinesia of mice. The compound of the invention can be used as a DA control agent, aniNOS control agent and an NMDA receptor antagonist; and the compound can be applied to the drug for treating Parkinson's diseases, particularly for treating behavior disorder and diseases caused by neuronal apoptosis.